Isorhamnetin protects against doxorubicin-induced cardiotoxicity in vivo and in vitro.

Doxorubicin (Dox) is an anthracycline antibiotic for cancer therapy with limited usage due to cardiotoxicity. Isorhamnetin is a nature antioxidant with obvious cardiac protective effect. The aim of this study is going to investigate the possible protective effect of isorhamnetin against Dox-induced...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Jing Sun, Guibo Sun, Xiangbao Meng, Hongwei Wang, Yun Luo, Meng Qin, Bo Ma, Min Wang, Dayong Cai, Peng Guo, Xiaobo Sun
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Public Library of Science (PLoS) 2013-01-01
Seri Bilgileri:PLoS ONE
Online Erişim:http://europepmc.org/articles/PMC3665796?pdf=render
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller